Terms: = Leukemia AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2
20 results:
1. Transplantation of human adipose-derived stem cells overexpressing LIF/IFN-β promotes recovery in experimental autoimmune encephalomyelitis (EAE).
Yousefi M; Nabipour A; Ganjalikhani Hakemi M; Ashja-Arvan M; Amirpour N; Salehi H
Sci Rep; 2022 Oct; 12(1):17835. PubMed ID: 36284106
[TBL] [Abstract] [Full Text] [Related]
2. Oligodendrocyte progenitor proliferation is disinhibited following traumatic brain injury in leukemia inhibitory factor heterozygous mice.
Frondelli MJ; Mather ML; Levison SW
J Neurosci Res; 2022 Feb; 100(2):578-597. PubMed ID: 34811802
[TBL] [Abstract] [Full Text] [Related]
3. RELA Fusion-Positive Ependymoma in a Child with Down Syndrome: A Case Report.
Chan JL; Kashanian A; Bannykh SI; Majlessipour F; Breunig JJ; Danielpour M
Pediatr Neurosurg; 2021; 56(2):146-151. PubMed ID: 33690230
[TBL] [Abstract] [Full Text] [Related]
4. Chromosome Translocation t(14;21)(q11;q22) Activates Both
Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
[TBL] [Abstract] [Full Text] [Related]
5. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
6. The oligodendrocyte lineage transcription factor 2 (olig2) is epigenetically regulated in acute myeloid leukemia.
Yalcin A; Kovarbasic M; Wehrle J; Claus R; Becker H; Abdelkarim M; Gaidzik VI; Schmidts A; Wäsch R; Pahl HL; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
Exp Hematol; 2017 Nov; 55():76-85.e3. PubMed ID: 28760688
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
Hiller JK; Schmoor C; Gaidzik VI; Schmidt-Salzmann C; Yalcin A; Abdelkarim M; Blagitko-Dorfs N; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
Ann Hematol; 2017 Apr; 96(4):559-565. PubMed ID: 28058491
[TBL] [Abstract] [Full Text] [Related]
8. The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.
Pétigny-Lechartier C; Duboc C; Jebahi A; Louis MH; Abeilard E; Denoyelle C; Gauduchon P; Poulain L; Villedieu M
Mol Cancer Ther; 2017 Jan; 16(1):102-115. PubMed ID: 27980105
[TBL] [Abstract] [Full Text] [Related]
9. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
[TBL] [Abstract] [Full Text] [Related]
10. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
[TBL] [Abstract] [Full Text] [Related]
11. MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.
Yalcin A; Kreutz C; Pfeifer D; Abdelkarim M; Klaus G; Timmer J; Lübbert M; Hackanson B
Leuk Res; 2013 Jan; 37(1):102-11. PubMed ID: 23062266
[TBL] [Abstract] [Full Text] [Related]
12. CpG island methylation profiling in human melanoma cell lines.
Tellez CS; Shen L; Estécio MR; Jelinek J; Gershenwald JE; Issa JP
Melanoma Res; 2009 Jun; 19(3):146-55. PubMed ID: 19441164
[TBL] [Abstract] [Full Text] [Related]
13. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract] [Full Text] [Related]
14. Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses.
Clase AC; Dimcheff DE; Favara C; Dorward D; McAtee FJ; Parrie LE; Ron D; Portis JL
Am J Pathol; 2006 Sep; 169(3):1026-38. PubMed ID: 16936275
[TBL] [Abstract] [Full Text] [Related]
15. olig2 (bhlhb1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract] [Full Text] [Related]
17. Negative regulatory effect of an oligodendrocytic bHLH factor olig2 on the astrocytic differentiation pathway.
Fukuda S; Kondo T; Takebayashi H; Taga T
Cell Death Differ; 2004 Feb; 11(2):196-202. PubMed ID: 14576772
[TBL] [Abstract] [Full Text] [Related]
18. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
Gryaznov SM
Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
[TBL] [Abstract] [Full Text] [Related]
19. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the bhlhb1 gene.
Wang J; Jani-Sait SN; Escalon EA; Carroll AJ; de Jong PJ; Kirsch IR; Aplan PD
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3497-502. PubMed ID: 10737801
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probes.
Casarino L; Carbone C; Capucci MA; Izzi T; Ferrara GB
Bone Marrow Transplant; 1992 Aug; 10(2):165-70. PubMed ID: 1356057
[TBL] [Abstract] [Full Text] [Related]
